Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner.

New test from Aberdeen University to offer better cancer prediction

Aberdeen University
Aberdeen University

Scientists at Aberdeen University have broken new ground with a test to detect the likelihood of developing one of the most common cancers.

The process will determine whether or not non-cancerous growths in the colon – known as polyps – are likely to progress into cancerous tumours.

The number of people diagnosed with polyps has risen since the introduction of routine bowel screening in Scotland in 2007.

The normal course of treatment once the growths have been identified in the colon is to remove them.

However, the new study, led by Dr Janice Drew, senior research fellow of the University’s Rowett Institute of Nutrition and Health, found that genes associated with cell changes can indicate the development of cancer before the tissue itself is recognisable as cancerous.

It is hoped testing the molecules behind the changes will help to better predict the likelihood of whether cancer may develop in the future.

Colon cancer cells
Colon cancer cells

Dr Drew said: “Currently, polyp size and number are the only predictors for screened patients at risk of developing colon cancer in the future, but this is not a sensitive measure of future risk of cancer.

“In addition, although visual assessment of the polyps and the degree of variation from normal colon tissue is made by trained medical staff, there is still a degree of variation.

“Consequently, large numbers of patients who may not develop a cancer still have to go through bowel screening to check for the presence of polyps or development of cancer.

“The development of an objective and effective test would have significant benefits in the fight against colon cancer.”

Colorectal cancer is the fourth most common cause of death from the disease, accounting for 8% of all cancer deaths.

Already a subscriber? Sign in